taurine has been researched along with Diabetes Mellitus, Adult-Onset in 61 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations." | 9.41 | The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect. ( Ahmed, K; Choi, HN; Yim, JE, 2023) |
| "We genotyped 31 diabetes-associated variants to calculate a genetic risk score (GRS) and measured plasma taurine levels and glycemic traits among participants from the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial." | 9.22 | Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets. ( Bray, GA; Ceglarek, U; Heianza, Y; Huang, T; Ma, W; Qi, L; Sacks, FM; Thiery, J; Wang, T; Zheng, Y, 2016) |
| "Betaine is highly individual in overweight people with diabetes." | 9.20 | Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. ( Chambers, ST; Elmslie, JL; Florkowski, CM; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Slow, S, 2015) |
| "Study on the influence of taurines (Dibicor) on metabolic indicators in patients with of metabolic syndrome showed improvement in carbohydrate metabolism and lipid profile in patients with type 2 pancreatic diabetes." | 7.77 | [Clinical effects of application of taurines in patients with metabolic syndrome]. ( Manovitskaia, AV, 2011) |
| "Obesity, type 2 diabetes, and their associated comorbidities impact brain metabolism and function and constitute risk factors for cognitive impairment." | 6.82 | Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes. ( Duarte, JMN; García-Serrano, AM; Rafiee, Z, 2022) |
| "The prevalence of type 2 diabetes mellitus (T2DM) is increasing with an epidemic growth rate." | 6.71 | Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. ( Brøns, C; Dyerberg, J; Spohr, C; Storgaard, H; Vaag, A, 2004) |
| "This review explores the potential benefits of taurine in ameliorating the metabolic disorders of obesity and type 2 diabetes (T2D), highlighting the factors that bridge these associations." | 5.41 | The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect. ( Ahmed, K; Choi, HN; Yim, JE, 2023) |
| "We genotyped 31 diabetes-associated variants to calculate a genetic risk score (GRS) and measured plasma taurine levels and glycemic traits among participants from the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial." | 5.22 | Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets. ( Bray, GA; Ceglarek, U; Heianza, Y; Huang, T; Ma, W; Qi, L; Sacks, FM; Thiery, J; Wang, T; Zheng, Y, 2016) |
| "Betaine is highly individual in overweight people with diabetes." | 5.20 | Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. ( Chambers, ST; Elmslie, JL; Florkowski, CM; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Slow, S, 2015) |
| ", methionine, total cysteine (tCys), total homocysteine (tHcy), cystathionine, total glutathione (tGSH), and taurine, are potential risk factors for obesity and cardiometabolic disorders." | 4.31 | The Associations of Habitual Intake of Sulfur Amino Acids, Proteins and Diet Quality with Plasma Sulfur Amino Acid Concentrations: The Maastricht Study. ( Bastani, NE; Dagnelie, PC; Elshorbagy, AK; Eussen, SJPM; Grootswagers, P; Kožich, V; Olsen, T; Refsum, H; Retterstøl, K; Stehouwer, CD; Stolt, ETK; Tore, EC; van Greevenbroek, MMJ; Vinknes, KJ, 2023) |
| "To investigate diabetic retinopathy (DR), plasma long pentraxin-3 (PTX-3) and taurine levels, and systemic factors in patients with type 2 diabetes mellitus (DM)." | 4.02 | New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels. ( Erdenen, F; Güngel, H; Kilic Muftuoglu, I; Ogreden, T; Pasaoglu, I; Sak, D, 2021) |
| " Importantly, angiotensin II (AngII), independently of its vasoconstrictor action, causes β-cell inflammation and dysfunction, which may be an early step in the development of type 2 diabetes." | 3.85 | Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response. ( Chan, SMH; Herbert, TP; Ku, JM; Lau, YS; Miller, AA; Potocnik, S; Woodman, OL; Ye, JM, 2017) |
| "Study on the influence of taurines (Dibicor) on metabolic indicators in patients with of metabolic syndrome showed improvement in carbohydrate metabolism and lipid profile in patients with type 2 pancreatic diabetes." | 3.77 | [Clinical effects of application of taurines in patients with metabolic syndrome]. ( Manovitskaia, AV, 2011) |
| " Taurine supplementation also improved hyperglycemia and insulin resistance and increased muscle glycogen content in the OLETF rats." | 3.72 | Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats. ( Harada, N; Mawatari, K; Morishima, M; Nakaya, Y; Ninomiya, C; Osako, Y; Takahashi, A, 2004) |
| "We aimed to investigate the effects of an 8-week total-body resistance exercise (TRX) suspension training intervention combined with taurine supplementation on body composition, blood glucose, and lipid markers in T2D females." | 3.01 | The Effects of TRX Suspension Training Combined with Taurine Supplementation on Body Composition, Glycemic and Lipid Markers in Women with Type 2 Diabetes. ( Ashtary-Larky, D; Bagheri, R; Cheraghloo, N; Samadpour Masouleh, S; Siahkouhian, M; Suzuki, K; Wong, A; Yousefi Bilesvar, O, 2021) |
| "Obesity, type 2 diabetes, and their associated comorbidities impact brain metabolism and function and constitute risk factors for cognitive impairment." | 2.82 | Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes. ( Duarte, JMN; García-Serrano, AM; Rafiee, Z, 2022) |
| "Differences in BA profiles with type 2 diabetes mellitus (T2D) remain incompletely understood." | 2.79 | Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. ( Barbato, C; Goldfine, AB; Houten, SM; Patti, ME; Wewalka, M, 2014) |
| "Increased urinary betaine excretions in type 2 diabetes are further increased by fibrate treatment, sometimes to more than their dietary intake." | 2.79 | Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. ( Chambers, ST; Elmslie, JL; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Parry-Strong, A; Slow, S, 2014) |
| "The prevalence of type 2 diabetes mellitus (T2DM) is increasing with an epidemic growth rate." | 2.71 | Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. ( Brøns, C; Dyerberg, J; Spohr, C; Storgaard, H; Vaag, A, 2004) |
| "Taurine is a conditionally essential amino acid present in the body in free form." | 2.55 | Prophylactic role of taurine and its derivatives against diabetes mellitus and its related complications. ( Basak, P; Ghosh, S; Kundu, M; Sarkar, P; Sil, PC, 2017) |
| "Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus." | 2.44 | Taurine-diabetes interaction: from involvement to protection. ( Gupta, RC; Kim, SJ; Lee, HW, 2007) |
| "Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus." | 2.44 | Taurine-diabetes interaction: from involvement to protection. ( Gupta, H; Kim, SJ; Lee, W; Ramesh, C, 2007) |
| "Taurine has demonstrated promising actions in vitro, and as a result clinical trials have begun to investigate its effects on various diseases." | 2.43 | Is taurine a functional nutrient? ( Bouckenooghe, T; Remacle, C; Reusens, B, 2006) |
| "Taurine is a semiessential amino acid, and its deficiency is involved in retinal and cardiac degenerations." | 2.42 | Is taurine beneficial in reducing risk factors for diabetes mellitus? ( Bennardini, F; Di Leo, MA; Franconi, F; Ghirlanda, G, 2004) |
| "Taurine is a crucial amino acid in the human body." | 1.91 | Taurine reduces apoptosis mediated by endoplasmic reticulum stress in islet β-cells induced by high-fat and -glucose diets. ( Bian, Y; Dai, J; Fu, Z; Hu, J; Li, C; Lin, S; Ma, Y; Meng, L; Wang, J; Wu, Y; Yin, D; Zhang, X; Zhao, D, 2023) |
| "Taurine could inhibit hippocampus neuron apoptosis via NGF-Akt/Bad pathway." | 1.56 | Taurine inhibits neuron apoptosis in hippocampus of diabetic rats and high glucose exposed HT-22 cells via the NGF-Akt/Bad pathway. ( Che, X; Chen, X; Li, K; Li, Q; Li, S; Li, Y; Liu, X; Liu, Y; Luo, M; Ma, J; Piao, F; Shi, X; Wu, P; Zhang, C; Zhang, M, 2020) |
| " bioavailability yet retaining its potency." | 1.39 | Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release. ( Alvarez Sanchez, R; Beauchamp, J; Conde-Knape, K; Dehmlow, H; Iglesias, A; Mattei, P; Raab, S; Sewing, S; Sprecher, U; Ullmer, C, 2013) |
| "The preventive effect of taurine on diabetic nephropathy was investigated by detecting blood glucose, lipid metabolism, kidney function and glomerular basement membrane metabolism." | 1.36 | Preventive effect of taurine on experimental type II diabetic nephropathy. ( Hu, J; Lin, S; Liu, M; Luan, X; Lv, Q; Wu, G; Yang, J; Zhao, H, 2010) |
| "Taurine could enhance the ability of oxidation resistance, improve blood rheology property in diabetic rats, at the same time it could be beneficial to prevent and cure the development of diabetic blood vessel complication." | 1.36 | [Effects of taurine on hemorheology of rats with type 2 diabetes]. ( Dong, SY; Kong, XY; Men, XL; Zhang, FF; Zhang, YM; Zhao, LJ, 2010) |
| "Taurine was given in drinking water at the level of 5% (w/v) for seven days." | 1.30 | Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice. ( Kim, H; Lim, E; Park, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (6.56) | 18.2507 |
| 2000's | 15 (24.59) | 29.6817 |
| 2010's | 28 (45.90) | 24.3611 |
| 2020's | 14 (22.95) | 2.80 |
| Authors | Studies |
|---|---|
| Samadpour Masouleh, S | 1 |
| Bagheri, R | 1 |
| Ashtary-Larky, D | 1 |
| Cheraghloo, N | 1 |
| Wong, A | 1 |
| Yousefi Bilesvar, O | 1 |
| Suzuki, K | 1 |
| Siahkouhian, M | 1 |
| Yang, X | 1 |
| Jiang, W | 1 |
| Cheng, J | 1 |
| Hao, J | 1 |
| Han, F | 1 |
| Zhang, Y | 2 |
| Xu, J | 2 |
| Shan, C | 1 |
| Wang, J | 2 |
| Yang, Y | 1 |
| Yang, J | 2 |
| Chang, B | 1 |
| Wei, W | 1 |
| Wang, X | 2 |
| Wei, Y | 1 |
| Liu, S | 3 |
| Gao, S | 1 |
| Tian, H | 1 |
| Su, D | 1 |
| Rafiee, Z | 1 |
| García-Serrano, AM | 1 |
| Duarte, JMN | 1 |
| Münzker, J | 1 |
| Haase, N | 1 |
| Till, A | 1 |
| Sucher, R | 1 |
| Haange, SB | 1 |
| Nemetschke, L | 1 |
| Gnad, T | 1 |
| Jäger, E | 1 |
| Chen, J | 1 |
| Riede, SJ | 1 |
| Chakaroun, R | 1 |
| Massier, L | 1 |
| Kovacs, P | 1 |
| Ost, M | 1 |
| Rolle-Kampczyk, U | 1 |
| Jehmlich, N | 1 |
| Weiner, J | 1 |
| Heiker, JT | 1 |
| Klöting, N | 1 |
| Seeger, G | 1 |
| Morawski, M | 1 |
| Keitel, V | 1 |
| Pfeifer, A | 1 |
| von Bergen, M | 1 |
| Heeren, J | 1 |
| Krügel, U | 1 |
| Fenske, WK | 1 |
| Sevilla-Gonzalez, MDR | 1 |
| Manning, AK | 1 |
| Westerman, KE | 1 |
| Aguilar-Salinas, CA | 1 |
| Deik, A | 1 |
| Clish, CB | 1 |
| Zhao, D | 1 |
| Zhang, X | 4 |
| Bian, Y | 1 |
| Meng, L | 1 |
| Wu, Y | 1 |
| Ma, Y | 1 |
| Li, C | 2 |
| Fu, Z | 1 |
| Dai, J | 1 |
| Yin, D | 1 |
| Lin, S | 2 |
| Hu, J | 2 |
| Tore, EC | 1 |
| Eussen, SJPM | 1 |
| Bastani, NE | 1 |
| Dagnelie, PC | 1 |
| Elshorbagy, AK | 1 |
| Grootswagers, P | 1 |
| Kožich, V | 1 |
| Olsen, T | 1 |
| Refsum, H | 1 |
| Retterstøl, K | 1 |
| Stehouwer, CD | 1 |
| Stolt, ETK | 1 |
| Vinknes, KJ | 1 |
| van Greevenbroek, MMJ | 1 |
| Ahmed, K | 1 |
| Choi, HN | 1 |
| Yim, JE | 1 |
| Wu, P | 1 |
| Shi, X | 1 |
| Luo, M | 1 |
| Li, K | 1 |
| Zhang, M | 1 |
| Ma, J | 1 |
| Li, Y | 2 |
| Liu, Y | 2 |
| Zhang, C | 1 |
| Liu, X | 2 |
| Li, S | 1 |
| Li, Q | 1 |
| Chen, X | 1 |
| Che, X | 1 |
| Piao, F | 1 |
| Maleki, V | 2 |
| Alizadeh, M | 2 |
| Esmaeili, F | 2 |
| Mahdavi, R | 1 |
| Wang, L | 1 |
| Yang, C | 1 |
| Song, F | 1 |
| Liu, Z | 1 |
| Kheirouri, S | 1 |
| Güngel, H | 1 |
| Erdenen, F | 1 |
| Pasaoglu, I | 1 |
| Sak, D | 1 |
| Ogreden, T | 1 |
| Kilic Muftuoglu, I | 1 |
| Aichler, M | 1 |
| Borgmann, D | 1 |
| Krumsiek, J | 1 |
| Buck, A | 1 |
| MacDonald, PE | 1 |
| Fox, JEM | 1 |
| Lyon, J | 1 |
| Light, PE | 1 |
| Keipert, S | 1 |
| Jastroch, M | 1 |
| Feuchtinger, A | 1 |
| Mueller, NS | 1 |
| Sun, N | 1 |
| Palmer, A | 1 |
| Alexandrov, T | 1 |
| Hrabe de Angelis, M | 1 |
| Neschen, S | 1 |
| Tschöp, MH | 1 |
| Walch, A | 1 |
| Chan, SMH | 1 |
| Lau, YS | 1 |
| Miller, AA | 1 |
| Ku, JM | 1 |
| Potocnik, S | 1 |
| Ye, JM | 1 |
| Woodman, OL | 1 |
| Herbert, TP | 1 |
| Sarkar, P | 1 |
| Basak, P | 1 |
| Ghosh, S | 1 |
| Kundu, M | 1 |
| Sil, PC | 2 |
| Xu, LP | 1 |
| Wang, Q | 1 |
| Yang, B | 1 |
| Wei, M | 2 |
| Shao, Y | 1 |
| Liu, QR | 1 |
| Wu, QZ | 1 |
| Zhong, MW | 1 |
| Liu, SZ | 1 |
| Zhang, GY | 1 |
| Hu, SY | 1 |
| Merino, J | 1 |
| Leong, A | 1 |
| Liu, CT | 1 |
| Porneala, B | 1 |
| Walford, GA | 1 |
| von Grotthuss, M | 1 |
| Wang, TJ | 1 |
| Flannick, J | 1 |
| Dupuis, J | 1 |
| Levy, D | 1 |
| Gerszten, RE | 1 |
| Florez, JC | 1 |
| Meigs, JB | 1 |
| Ullmer, C | 1 |
| Alvarez Sanchez, R | 1 |
| Sprecher, U | 1 |
| Raab, S | 1 |
| Mattei, P | 1 |
| Dehmlow, H | 1 |
| Sewing, S | 1 |
| Iglesias, A | 1 |
| Beauchamp, J | 1 |
| Conde-Knape, K | 1 |
| Manna, P | 1 |
| Das, J | 1 |
| Tang, C | 2 |
| Marchand, K | 1 |
| Lam, L | 1 |
| Lux-Lantos, V | 1 |
| Thyssen, SM | 1 |
| Guo, J | 1 |
| Giacca, A | 2 |
| Arany, E | 1 |
| Wewalka, M | 1 |
| Patti, ME | 1 |
| Barbato, C | 1 |
| Houten, SM | 1 |
| Goldfine, AB | 1 |
| Lekishvili, SE | 1 |
| Szwergold, BS | 1 |
| Miller, CB | 1 |
| McEntyre, CJ | 2 |
| Lever, M | 2 |
| Chambers, ST | 2 |
| George, PM | 2 |
| Slow, S | 2 |
| Elmslie, JL | 2 |
| Florkowski, CM | 1 |
| Lunt, H | 2 |
| Krebs, JD | 2 |
| Parry-Strong, A | 1 |
| Wang, Y | 2 |
| Zhong, M | 1 |
| Liu, T | 1 |
| Han, H | 1 |
| Zhang, G | 1 |
| Wu, Q | 1 |
| Hu, S | 1 |
| Zheng, Y | 1 |
| Ceglarek, U | 1 |
| Huang, T | 1 |
| Wang, T | 1 |
| Heianza, Y | 1 |
| Ma, W | 1 |
| Bray, GA | 1 |
| Thiery, J | 1 |
| Sacks, FM | 1 |
| Qi, L | 1 |
| Gossai, D | 1 |
| Lau-Cam, CA | 1 |
| de Oliveira, CA | 1 |
| Latorraca, MQ | 1 |
| de Mello, MA | 1 |
| Carneiro, EM | 1 |
| Wu, G | 1 |
| Liu, M | 1 |
| Luan, X | 1 |
| Lv, Q | 1 |
| Zhao, H | 1 |
| Zhao, LC | 1 |
| Zhang, XD | 1 |
| Liao, SX | 1 |
| Gao, HC | 1 |
| Wang, HY | 1 |
| Lin, DH | 1 |
| Meng, F | 1 |
| Raleigh, DP | 1 |
| Zhang, FF | 1 |
| Zhang, YM | 1 |
| Men, XL | 1 |
| Zhao, LJ | 1 |
| Kong, XY | 1 |
| Dong, SY | 1 |
| Bianchi, L | 1 |
| Lari, R | 1 |
| Anichini, R | 2 |
| De Bellis, A | 1 |
| Berti, A | 1 |
| Napoli, Z | 1 |
| Seghieri, G | 2 |
| Franconi, F | 3 |
| Manovitskaia, AV | 1 |
| Lee, E | 1 |
| Ryu, GR | 1 |
| Ko, SH | 1 |
| Ahn, YB | 1 |
| Yoon, KH | 1 |
| Ha, H | 1 |
| Song, KH | 1 |
| Mikami, N | 1 |
| Hosokawa, M | 1 |
| Miyashita, K | 1 |
| Kim, KS | 1 |
| Oh, DH | 1 |
| Kim, JY | 1 |
| Lee, BG | 1 |
| You, JS | 1 |
| Chang, KJ | 1 |
| Chung, HJ | 1 |
| Yoo, MC | 1 |
| Yang, HI | 1 |
| Kang, JH | 1 |
| Hwang, YC | 1 |
| Ahn, KJ | 1 |
| Chung, HY | 1 |
| Jeong, IK | 1 |
| Liu, C | 1 |
| Cai, S | 1 |
| Dong, J | 1 |
| Li, X | 1 |
| Feng, J | 1 |
| Chen, Z | 2 |
| Nishimura, N | 1 |
| Umeda, C | 1 |
| Ona, H | 1 |
| Yokogoshi, H | 1 |
| Chauncey, KB | 1 |
| Tenner, TE | 1 |
| Lombardini, JB | 1 |
| Jones, BG | 1 |
| Brooks, ML | 1 |
| Warner, RD | 1 |
| Davis, RL | 1 |
| Ragain, RM | 1 |
| Di Leo, MA | 1 |
| Bennardini, F | 2 |
| Ghirlanda, G | 1 |
| Brøns, C | 2 |
| Spohr, C | 2 |
| Storgaard, H | 1 |
| Dyerberg, J | 2 |
| Vaag, A | 2 |
| Harada, N | 1 |
| Ninomiya, C | 1 |
| Osako, Y | 1 |
| Morishima, M | 1 |
| Mawatari, K | 1 |
| Takahashi, A | 1 |
| Nakaya, Y | 1 |
| Winther, K | 1 |
| Cao, L | 1 |
| Zeng, Q | 1 |
| Dai, T | 1 |
| Hu, D | 1 |
| Huang, K | 1 |
| Li, D | 1 |
| Zhang, J | 1 |
| Sharma, R | 1 |
| Li, F | 1 |
| Abatan, OI | 1 |
| Kim, H | 2 |
| Burnett, D | 1 |
| Larkin, D | 1 |
| Obrosova, IG | 1 |
| Stevens, MJ | 1 |
| Bouckenooghe, T | 1 |
| Remacle, C | 1 |
| Reusens, B | 1 |
| Merheb, M | 1 |
| Daher, RT | 1 |
| Nasrallah, M | 1 |
| Sabra, R | 1 |
| Ziyadeh, FN | 1 |
| Barada, K | 1 |
| Oprescu, AI | 1 |
| Bikopoulos, G | 1 |
| Naassan, A | 1 |
| Allister, EM | 1 |
| Park, E | 1 |
| Uchino, H | 1 |
| Lewis, GF | 1 |
| Fantus, IG | 1 |
| Rozakis-Adcock, M | 1 |
| Wheeler, MB | 1 |
| Kim, SJ | 2 |
| Gupta, RC | 1 |
| Lee, HW | 1 |
| Ramesh, C | 1 |
| Gupta, H | 1 |
| Lee, W | 1 |
| Mattana, A | 1 |
| Miceli, M | 1 |
| Ciuti, M | 1 |
| Milan, M | 1 |
| Gironi, A | 1 |
| Bartomomei, G | 1 |
| Elizarova, EP | 1 |
| Nedosugova, LV | 1 |
| Lim, E | 1 |
| Park, S | 1 |
| Nakamura, T | 1 |
| Ushiyama, C | 1 |
| Suzuki, S | 1 |
| Shimada, N | 1 |
| Ohmuro, H | 1 |
| Ebihara, I | 1 |
| Koide, H | 1 |
| De Luca, G | 1 |
| Calpona, PR | 1 |
| Caponetti, A | 1 |
| Romano, G | 1 |
| Di Benedetto, A | 1 |
| Cucinotta, D | 1 |
| Di Giorgio, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Taurine on Glycemic, Lipid and Inflammatory Profile in Individuals With Type 2 Diabetes: a Randomized Clinical Trial[NCT04874012] | Phase 2 | 94 participants (Anticipated) | Interventional | 2021-06-12 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for taurine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes.
Topics: Diabetes Mellitus, Type 2; Dietary Supplements; Hippocampus; Humans; Metabolic Syndrome; Neuroprotec | 2022 |
The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Obesity; Taurine | 2023 |
Prophylactic role of taurine and its derivatives against diabetes mellitus and its related complications.
Topics: Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Type 2; Humans; Oxidative Stress; | 2017 |
Role of sulfur containing amino acids as an adjuvant therapy in the prevention of diabetes and its associated complications.
Topics: 3T3-L1 Cells; Amino Acids, Sulfur; Animals; Blood Glucose; Cells, Cultured; Cysteine; Diabetes Melli | 2013 |
Mechanisms of insulin secretion in malnutrition: modulation by amino acids in rodent models.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Diabetes Mellitus, Type 2; Dietary Supplement | 2011 |
[Taurin in combined treatment of metabolic syndrome and diabetes mellitus].
Topics: Comorbidity; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Multicenter Studies as Topic; Pr | 2011 |
Is taurine beneficial in reducing risk factors for diabetes mellitus?
Topics: Diabetes Mellitus, Type 2; Glucose; Humans; Risk Factors; Taurine | 2004 |
Is taurine a functional nutrient?
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Immunologic Factors; Liver Diseases; Nervous System Dise | 2006 |
Taurine-diabetes interaction: from involvement to protection.
Topics: Animals; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes | 2007 |
Taurine-diabetes interaction: from involvement to protection.
Topics: Aging; Animals; Antioxidants; Diabetes Complications; Diabetes Mellitus, Type 2; Exercise; Humans; M | 2007 |
11 trials available for taurine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The Effects of TRX Suspension Training Combined with Taurine Supplementation on Body Composition, Glycemic and Lipid Markers in Women with Type 2 Diabetes.
Topics: Biomarkers; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Diet; Dietary Supplements; E | 2021 |
The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dietary Supplem | 2020 |
The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Double-B | 2021 |
Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.
Topics: Adult; Bile Acids and Salts; Blood Glucose; Cohort Studies; Cross-Sectional Studies; Diabetes Mellit | 2014 |
Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period.
Topics: Aged; Betaine; Choline; Diabetes Mellitus, Type 2; Female; Glycerylphosphorylcholine; Humans; Male; | 2015 |
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes.
Topics: Adult; Aged; Betaine; Bezafibrate; Choline; Diabetes Mellitus, Type 2; Female; Glycerylphosphorylcho | 2014 |
Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Genetic Predisposition to Disease; G | 2016 |
The effect of taurine supplementation on patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Plac | 2003 |
Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus.
Topics: Adult; Aged; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method | 2004 |
No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus.
Topics: Adenosine Diphosphate; Adult; Aged; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Dieta | 2005 |
First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes.
Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Di | 1996 |
40 other studies available for taurine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Reductions in Intestinal Taurine-Conjugated Bile Acids and Short-Chain Fatty Acid-Producing Bacteria Might be Novel Mechanisms of Type 2 Diabetes Mellitus in Otsuka Long-Evans Tokushima Fatty Rats.
Topics: Animals; Bacteria; Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Vola | 2022 |
lncRNA TUG1 protects intestinal epithelial cells from damage induced by high glucose and high fat via AMPK/SIRT1.
Topics: AMP-Activated Protein Kinases; Apoptosis; Diabetes Mellitus, Type 2; Epithelial Cells; Glucose; Huma | 2022 |
Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Topics: Adipose Tissue; Animals; Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Gastr | 2022 |
Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes.
Topics: Acetylgalactosamine; Biomarkers; Diabetes Mellitus, Type 2; Diet, Reducing; Dietary Proteins; Glucos | 2022 |
Taurine reduces apoptosis mediated by endoplasmic reticulum stress in islet β-cells induced by high-fat and -glucose diets.
Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Diet, High-Fat; Endoplasmic Reticulum Stress; Glucose | 2023 |
The Associations of Habitual Intake of Sulfur Amino Acids, Proteins and Diet Quality with Plasma Sulfur Amino Acid Concentrations: The Maastricht Study.
Topics: Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cystathionine; Cysteine; Diab | 2023 |
Taurine inhibits neuron apoptosis in hippocampus of diabetic rats and high glucose exposed HT-22 cells via the NGF-Akt/Bad pathway.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Diabetes Mellitus, Experimental; Diabetes Mellitus | 2020 |
Therapeutic Effectiveness of
Topics: Amino Acids; Animals; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Gardenia; Humans; Male; Meta | 2020 |
New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; C-Reactive Protein; Cross-Sectional Studies; | 2021 |
N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes.
Topics: Animals; Carnitine; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Secretion; Insulin-Secreting | 2017 |
Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response.
Topics: Angiotensin II; Animals; Cell Line, Tumor; Cytokines; Diabetes Mellitus, Type 2; eIF-2 Kinase; Endop | 2017 |
Synergistic Inhibitory Effect of GQDs-Tramiprosate Covalent Binding on Amyloid Aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidogenic Proteins; Amyloidosis; Diabetes Mellitus, Ty | 2018 |
Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries.
Topics: Animals; Bariatric Surgery; Bile Acids and Salts; Blood Glucose; Body Weight; Diabetes Mellitus, Exp | 2018 |
Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; Computational Biology; Diabetes Mellitus, Type 2; Fema | 2018 |
Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
Topics: Animals; Cell Line; CHO Cells; Cricetulus; Diabetes Mellitus, Type 2; Enteroendocrine Cells; Gastroi | 2013 |
Maternal taurine supplementation in rats partially prevents the adverse effects of early-life protein deprivation on β-cell function and insulin sensitivity.
Topics: Animals; C-Peptide; Diabetes Mellitus, Type 2; Diet, Protein-Restricted; Dietary Proteins; Dietary S | 2013 |
[The influence of C-taurine antioxidant complex on biochemical blood parameters in the process of treatment of patients with diabetes mellitus of type II with nonproliferative diabetic retinopathy].
Topics: Antioxidants; Ascorbic Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Lipid Metaboli | 2014 |
Potential of birds to serve as pathology-free models of type 2 diabetes, part 2: do high levels of carbonyl-scavenging amino acids (e.g., taurine) and low concentrations of methylglyoxal limit the production of advanced glycation end-products?
Topics: Albumins; Animals; Arginine; Birds; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructosamine; | 2014 |
Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Duo | 2016 |
The effects of taurine, taurine homologs and hypotaurine on cell and membrane antioxidative system alterations caused by type 2 diabetes in rat erythrocytes.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Male; Rats; Tauri | 2009 |
Preventive effect of taurine on experimental type II diabetic nephropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephrop | 2010 |
A metabonomic comparison of urinary changes in Zucker and GK rats.
Topics: Acids, Acyclic; Animals; Biomarkers; Creatine; Diabetes Mellitus, Type 2; Dimethylamines; Disease Mo | 2010 |
Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.
Topics: Amyloid; Benzenesulfonates; Diabetes Mellitus, Type 2; Heparitin Sulfate; Humans; Insulin-Secreting | 2011 |
[Effects of taurine on hemorheology of rats with type 2 diabetes].
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Erythrocyte Defo | 2010 |
Taurine transporter gene expression in peripheral mononuclear blood cells of type 2 diabetic patients.
Topics: Aged; Albuminuria; Amino Acids, Sulfur; Case-Control Studies; Chromatography, High Pressure Liquid; | 2012 |
[Clinical effects of application of taurines in patients with metabolic syndrome].
Topics: Adult; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Female; Humans; Lipids; Male; Metabolic S | 2011 |
Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Cyclic N-Oxides; Cytoprotection; Diabetes Mellitus, | 2011 |
Dietary combination of fish oil and taurine decreases fat accumulation and ameliorates blood glucose levels in type 2 diabetic/obese KK-A(y) mice.
Topics: Acyl-CoA Oxidase; Adipose Tissue, White; Adiposity; Animals; Diabetes Mellitus, Type 2; Fatty Acid S | 2012 |
Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.
Topics: Adipokines; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Dyslipidemias; G | 2012 |
Metabolomic profilings of urine and serum from high fat-fed rats via 1H NMR spectroscopy and pattern recognition.
Topics: 3-Hydroxybutyric Acid; Animals; Choline; Citric Acid; Creatinine; Diabetes Mellitus, Type 2; Dietary | 2013 |
The effect of taurine on plasma cholesterol concentration in genetic type 2 diabetic GK rats.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Body Weight; Cholesterol; Cholesterol, Dietary; Diabet | 2002 |
Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats.
Topics: Animal Nutritional Physiological Phenomena; Animals; Blood; Blood Glucose; Blood Pressure; Body Weig | 2004 |
Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.
Topics: Animals; Apoptosis; Biomarkers; Blood Glucose; Blotting, Western; Cardiomyopathies; Carotid Artery, | 2005 |
Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Disease Models, Animal; Ganglia, Spinal; Male; Neu | 2006 |
Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study.
Topics: Adult; Body Mass Index; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fem | 2007 |
Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo.
Topics: Acetylcysteine; Animals; Antioxidants; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Ac | 2007 |
Taurine levels in plasma and platelets in insulin-dependent and non-insulin-dependent diabetes mellitus: correlation with platelet aggregation.
Topics: Adult; Blood Platelets; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; | 1994 |
Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1998 |
Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy.
Topics: Albuminuria; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Matrix Metalloprot | 1999 |
Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetic patients.
Topics: Blood Platelets; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Taurine; Water-Electr | 2001 |